Minimally invasive surgery in the treatment of uterine fibroids

Česká verze

Authors: Renáta Hlistová
Authors place of work: Gynekologicko-porodní oddělení, Nemocnice ve Frýdku-Místku, p. o.
Published in the journal: Prakt Gyn 2015; 19(4): 219-223
Category: Gynekologie a porodnictví: Přehledový článek

Summary

Objective:
To report up-to date knowledge on minimally invasive surgery in the treatment of uterine fibroids.

Study design:
Review.

Methods:
Analysis of available literature resources.

Conclusion:
Uterine fibroids are the most common benign tumour occuring in women. Symptoms occurs by 25 % of women with uterine fibroids, but some may have abnormal uterine bleeding, pelvic pain, problems of oppression adjacent organs infertility and complication during the childbirth and pregnancy. The surgery treatment is prefer in the treatment of large myomas. Problems with treatment of fibroids applies not only to symptomatic patients who wish to preserve the uterus, but also women who have uterine fibroids negatively affect their reproduction. The surgical treatment dominates in the treatment of large myomas. Laparoscopic myomectomy is the best option by symptomatic patients with pregnancy plans. Laparoscopic occlusion of uterine arteries is an alternative method for women with multiple fibroids or myoma in unfavorable location. By women not wishing to preserve the uterus is suitable hysterectomy. Vaginal and laparoscopic approach is associated with faster recovery as compared with abdominal hysterectomy.

Key words:
uterine fibroids – hysteroscopy – laparoscopic hysterectomy

Zdroje

1. Agdi M, Tulandi T. Endoscopic management of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008; 22(4): 707–716.

2. Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Hum Reprod Update 2000; 6(6): 614–620.

3. Barbieri R. Ambulatory management of uterine leiomyomata. Clin Obstet Gynecol 1999; 42(2): 196–205.

4. Beckmann MW, Juhasz-Böss I, Denschlag D et al. Surgical methods for the treatment of uterine fibroids – risk of uterine sarcoma and problems of morcellation: position paper of the DGGG. Geburtshilfe Frauenheilkd 2015; 75(2):148–164.

5. Boosz AS, Reimer P, Matzko M. The conservative and interventional treatment of fibroids. Dtsch Arztlebl Int 2014; 111(51–52): 877–883.

6. Candiani GB, Fedele L, Parazzini F et al. Risk of reccurence after myomectomy. Br J Obset Gynaecol 1991; 98(4): 385–389.

7. Citterbart K et al. Gynekologie. Galén: Praha 2001. ISBN 80–7262–094–0.

8. Dubuisson JB, Fauconnier A, Deffarges JV et al. Pregnancy outcome and deliveries following laparoscopic myomectomy. Hum Reprod 2000; 15(4): 869–73.

9. Dubuisson JB, Fauconnier A, Chapron C et al. Second look after laparoscopic myomectomy. Hum Reprod 1998; 13(8): 2102–2106.

10. Falcone T, Walters M. Hysterectomy for benign disease. Obstet Gynecol 2008; 111(3): 753–767.

11. Fedele L, Parazzini F, Luchini L et al. Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study. Hum Reprod 1995; 10(7): 1795–1796.

12. Fernandez H, Sefrioui O, Virelizier C et al. Hysteroscopic resection of submucosal myomas in patients with infertility. Hum Reprod 2001; 16(7): 1489–1492.

13. Frishman GN, Jurema MW. Myomas and myomectomy. J Minim Invasive Gynecol 2005; 12(5): 443–456.

14. Hannoun-Lévi JM, Peiffert D, Hoffstetter S et al. Carcinoma of the cervical stump: retrospective analysis of 77 cases. Radiother Oncol 1997; 43(2): 147–153.

15. Härkki-Sirén P. Laparoscopic hysterectomy: outcome and complications in Finland. Academic Disertation. Medical Faculty of the University of Helsinki. 1999. WWW: <https://helda.helsinki.fi/bitstream/handle/10138/22885/laparosc.pdf?sequence=1>.

16. Holub M, Kužel, D. Minimálně invazivní operace v gynekologii. Grada: Praha 2005. ISBN 80–247–0834–5.

17. Hurst BS, Matthews ML, Marshburn PB. Laparoscopic myomectomy for symptomatic uterine myomas. Fertil Steril 2005; 83(1): 1–23.

18. Kužel D, Toth D, Hrazdirová L et al. Office hysteroscopy – state of the art. Čes Gynek 2006; 71(3): 220–225.

19. Lefebre G, Vilos G, Allaire C et al. The management of uterine leiomyomas. J Obset Gynaecol Can 2003; 25(5): 396–418.

20. Ligon AH, Morton CC. Leiomyomata: heritability and cytogenetic studies. Hum Reprod Update 2001; 7(1): 8–14.

21. Lumbiganon P, Rugpao S, Phandhu-fung S et al. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obset Gynaecol 1996; 103(9): 909–914.

22. Maheux-Lacroix S, Lemyre M, Couture V et al. Feasibility and safety of outpatient total laparoscopic hysterectomy. JSLS 2015; 19(1): e2014.00251.Dostupné z DOI: <http://dx.doi.org/10.4293/JSLS.2014.00251>.

23. Mára M, Fučíková Z, Mašata M et al. Management děložních myomů u žen ve fertilním věku. Česká Gynek 2003; 68(1): 30–36.

24. Mára M, Holub Z. Děložní myomy. Grada: Praha 2009. ISBN 978–80–247–1854–5.

25. Mára M Fučíková Z, Mašata M et al. Management děložních myomů u žen ve fertilním věku. Čes Gynek 2003; 68(1): 30.

26. Mára M, Kužel D, Kubínová K et al. Uterine artery embolization versus laparoscopic uterine artery occlusion: the outcomes of a prospective, nonrandomized clinical trial. Cardiovasc Intervent Radiol 2012; 35(5): 1041–1052.

27. Moroni R, Vieira C, Ferriani R. Pharmacological treatment of uterine fibroids. Ann Med Health Sci Res 2014; 4(Suppl 3): 185–192.

28. Paul PG, Prathap T, Kaur H et al. Secondary hemorrhage after total laparoscopic hysterectomy. JSLS 2014; 18(3): pii: e2014.00139.Dostupné z DOI: <http://dx.doi.org/10.4293/JSLS.2014.00139>.

29. Pellicano M, Bramante S, Cirillo D et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertil Steril 2003; 80(2): 441–444.

30. Saridogan E, Cutner A. Endoscopic management of uterine fibroids. Human Fertility 2006; 9(4): 201–208.

31. Sasaki KJ, Cholkeri-Singh A et al. Persistent bleeding after laparoscopic supracervical hysterectomy. JSLS 2014; 18(4): pii: e2014.002064. Dostupné z DOI: <http://dx.doi.org/10.4293/JSLS.2014.002064>.

32. Seracchioli R, Rossi S, Govoni F et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod 2000; 15(12): 2663–2668.

33. Sinha R, Sundaram M. Laparoscopic management of large myomas. J Gynecol Endosc Surg 2009; 1(2): 73–82.

34. Stewart EA, Morton CC. The genetics of uterine leiomyomata: what clinicians need to know. Obset Gynecol 2006; 107(4): 917–921.

35. Stoica RA, Bistriceanu I, Sima R et al. Laparoscopic myomectomy. J Med Life 2014; 7(4): 522–524.

36. Toro JR, Nickerson ML, Wei MH et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 2003; 73(1): 95–106.